Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.6 GBX | -1.48% | +3.10% | -0.60% |
Mar. 26 | Earnings Flash (NIOX.L) NIOX GROUP Reports FY23 Revenue GBP36.8M | MT |
Mar. 26 | Earnings Flash (NIOX.L) NIOX GROUP Posts FY23 EPS GBX2.38 | MT |
Business Summary
Number of employees: 92
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
NIOX
100.0
%
| 31 | 100.0 % | 37 | 100.0 % | +17.57% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Asia Pacific
37.5
%
| 11 | 34.2 % | 14 | 37.5 % | +28.97% |
European Union
28.0
%
| 10 | 30.4 % | 10 | 28.0 % | +8.42% |
United States
23.6
%
| 8 | 25.9 % | 9 | 23.6 % | +7.41% |
United Kingdom
9.0
%
| 3 | 8.9 % | 3 | 9.0 % | +17.86% |
Rest of World
1.9
%
| 0 | 0.6 % | 1 | 1.9 % | +250.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Roller
DFI | Director of Finance/CFO | 59 | 20-01-08 |
Jan Lundquist
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jonathan Emms
COO | Chief Operating Officer | - | 19-09-01 |
Investor Relations Contact | - | 20-10-31 | |
Nina Kataria
HRO | Human Resources Officer | - | 14-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Johnson
CHM | Chairman | 71 | 19-12-04 |
Michael Roller
DFI | Director of Finance/CFO | 59 | 20-01-08 |
Garry Watts
BRD | Director/Board Member | 67 | 20-03-01 |
Jonathan Emms
COO | Chief Operating Officer | - | 19-09-01 |
Director/Board Member | 60 | 18-02-07 | |
Sharon Curran
BRD | Director/Board Member | 56 | 18-02-07 |
Director/Board Member | 34 | 20-11-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 422,746,703 | 193,521,145 ( 45.78 %) | 0 | 45.78 % |
Company contact information
Niox Group Plc
Hayakawa Building The Oxford Science Park
OX4 4GB, Oxford
+44 3303 309 356
http://www.niox.comGroup companies
Name | Category and Sector |
---|---|
Circassia Ltd.
Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. |
Pharmaceuticals: Other
|
Sector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.60% | 352M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- CIR Stock
- Company NIOX Group Plc